Innospec (IOSP) Earns News Impact Score of 0.24

Headlines about Innospec (NASDAQ:IOSP) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Innospec earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news stories about the specialty chemicals company an impact score of 45.6655378295737 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

How to Become a New Pot Stock Millionaire

A number of brokerages recently issued reports on IOSP. Zacks Investment Research raised Innospec from a “sell” rating to a “hold” rating in a report on Thursday. BidaskClub upgraded Innospec from a “hold” rating to a “buy” rating in a research report on Thursday. Finally, ValuEngine upgraded Innospec from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $70.50.

NASDAQ IOSP opened at $73.75 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.15 and a quick ratio of 1.34. Innospec has a twelve month low of $54.10 and a twelve month high of $74.35. The stock has a market capitalization of $1,803.72, a P/E ratio of 15.83 and a beta of 1.03.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.47 EPS for the quarter, topping analysts’ consensus estimates of $1.13 by $0.34. The firm had revenue of $353.80 million during the quarter. Innospec had a net margin of 4.73% and a return on equity of 15.57%. sell-side analysts anticipate that Innospec will post 4.3 earnings per share for the current year.

In other Innospec news, insider Philip Curran sold 1,268 shares of the firm’s stock in a transaction that occurred on Wednesday, March 7th. The shares were sold at an average price of $68.24, for a total value of $86,528.32. Following the transaction, the insider now directly owns 2,998 shares of the company’s stock, valued at $204,583.52. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Philip John Boon sold 3,558 shares of the firm’s stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $69.69, for a total transaction of $247,957.02. Following the completion of the transaction, the vice president now directly owns 31,000 shares in the company, valued at $2,160,390. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 12,112 shares of company stock valued at $832,724. Company insiders own 2.02% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Innospec (IOSP) Earns News Impact Score of 0.24” was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives.

Insider Buying and Selling by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with's FREE daily email newsletter.

Leave a Reply